Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.

Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.

Item

http://www.wikidata.org/entity/Q34006865

Q34006865

about

A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteria Prospects offered by genome studies for combating meningococcal disease by vaccination.The msbB mutant of Neisseria meningitidis strain NMB has a defect in lipooligosaccharide assembly and transport to the outer membrane.Safety of a new conjugate meningococcal C vaccine in infants.Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.Control and lot release of meningococcal group C conjugate vaccines.Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals.Immunization strategies for the control of serogroup C meningococcal disease in developed countries.Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom Prevention of meningococcal serogroup C disease by NeisVac-C.Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.Advances with vaccination against Neisseria meningitidis.Evolving meningococcal immunization strategies.Regulation of capsule in Neisseria meningitidis.Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme.An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.First evidence for a covalent linkage between enterobacterial common antigen and lipopolysaccharide in Shigella sonnei phase II ECALPS.The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase.Spontaneous point mutations in the capsule synthesis locus leading to structural and functional changes of the capsule in serogroup A meningococcal populations

P2860

Q33334377-EFF2C11A-005C-4AC9-938A-25153FE0DD4D Q33788651-924E384B-E182-442C-8898-91BC994DA2EB Q34126015-345600A1-3C93-4A5C-B432-2934A9721C20 Q34145007-BB23DA6C-5694-45CB-8A32-601B6B358D62 Q34355276-1D5082EF-A49E-49D7-861A-2D8C414BC68E Q34581610-CA215C1A-1AF3-4212-850C-59161E78E9BF Q35271522-220000DE-71ED-4B8D-B4B1-EFD29282560E Q35783606-285DFEC2-EB0E-47D8-87C1-921457D75E5E Q35918490-EA63B0FB-374E-4C91-AB86-C0852153A550 Q35920353-C31F0E06-0D5E-4A0A-BBAF-C153488A18B0 Q35923662-5B5FA27C-68C2-47F6-83A2-261F9E9FB2B8 Q36045855-BC53682B-792C-437B-B224-0EF65309F08C Q36228084-33401AE0-8C1C-42A2-9C9E-7B840288B4A3 Q36445558-7091CC4E-66F2-48D3-B7DD-8727C8482E7C Q36690297-D8BA2C90-B77C-4CC4-815B-91BFC65CAE51 Q37099242-5C894125-90F1-4FD1-9955-86E6DBF330F6 Q37403478-DA25D9E7-80F4-448C-B1DC-DDF8B37C75D9 Q37595207-07690870-6915-46AA-8DC3-AE8E4E21D378 Q37857249-D5E006C0-1F9A-4FD4-BA16-148478BEC79F Q38040527-04AE147A-CC13-4BD0-8B74-150E3628761D Q38286082-2B9DB6E1-ED29-4735-9409-9BC201F085C4 Q38531723-C2B895E9-71B0-45CD-BB7D-ADBDCBE09BFC Q38812268-0EA5974D-29F3-47A6-A505-6D0EBDC9E74E Q39093233-2B219DFA-6DE9-4B59-8EFD-59D51E255DFE Q41903067-BEC46B14-CCB9-482A-B319-44A8245ACB0B Q45007519-A3E340BC-A355-4477-9486-B3B420FB197E Q58806131-F2B59B58-8B77-48B4-B747-2CB6200049A8

P2860

Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.

Item

http://www.wikidata.org/entity/Q34006865

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu